Olmesartan Medoxomil/Amlodipine Tablet 10/40 mg

Adult dose

This drug is taken once daily with water, regardless of meals. It is recommended to take at the same time each day (e.g., in the morning). The recommended doses are as follows: - 5/20 mg: Administer to patients whose blood pressure is not adequately controlled by monotherapy with amlodipine 5 mg or olmesartan medoxomil 20 mg. - 10/20 mg: Administer to patients whose blood pressure is not adequately controlled by olmesartan medoxomil 20 mg.

Child dose

Safety and efficacy have not been established for pediatric patients under 18 years old.

This drug may cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it must be discontinued immediately upon confirmation of pregnancy. This drug should not be taken by individuals with allergies to the active ingredient or similar components, pregnant or breastfeeding women, patients with severe liver impairment, those with severe aortic stenosis, biliary obstruction, patients on dialysis, shock patients, or specific diabetes patients. Patients with hypotension due to lack of fluid or salt, those sensitive to vasodilation, severe obstructive coronary artery disease, congestive heart failure, impaired kidney function, and liver disease should be cautious when taking this drug, and their condition should be closely monitored. Various adverse reactions such as dizziness, headache, hypotension, edema, dyspepsia, rash, etc., may occur during administration; if symptoms are severe or persistent, consult a doctor. Although this drug is different from beta-blockers, caution is needed during discontinuation to consider the risks that may arise from sudden withdrawal. Interactions may occur when used in combination with other medications affecting blood pressure control, therefore, it is essential to inform if taking any other medications. Pregnant or breastfeeding women should avoid or discontinue this drug due to the risks to the fetus or infant, especially consulting a doctor immediately if pregnancy is confirmed. Safety in children under 18 years of age has not been established, and it is not recommended. Elderly patients should start at a lower dose and be closely monitored, considering the possibility of reduced kidney and liver function. Overdosage can lead to hypotension, tachycardia, etc., necessitating immediate medical attention for appropriate treatment. This medication should be stored out of reach of children, away from direct sunlight and moisture, and should not be transferred to another container.

Serious side effects

Urticaria, severe swelling (edema), difficulty breathing, severe allergic reactions, severe skin reactions, liver abnormalities (jaundice), angioedema, acute renal failure, hyperkalemia, increased creatinine levels, elevated blood pressure, severe neurological symptoms, significant edema or urinary abnormalities, dizziness, cholelithiasis, female breast neoplasm, cerebral infarction exacerbation, gum bleeding

Mild side effects

Dizziness, headache, drowsiness, sensory disturbances, diminished sensitivity, palpitations, rapid pulse, hypotension, orthostatic hypotension, cough, nausea, vomiting, dyspepsia, diarrhea, constipation, dry mouth, epigastric pain, rash, muscle tension, limb pain, low back pain, increased urinary frequency, erectile dysfunction, peripheral edema, swelling, infiltrative edema, fatigue, weakness, facial edema, decreased potassium levels, increased creatinine levels, increased uric acid levels, increased gamma-glutamyl transpeptidase levels,

Store this medication in a tightly sealed container to protect it from air and moisture. It's important to maintain the storage temperature between 1 and 30 degrees Celsius to ensure the long-term effectiveness and safety of the drug.

Appearance

Brownish-red, round film-coated tablet

Package unit

28 tablets/box [14 tablets/PTP × 2]